[Osteoporosis--which therapy is confirmed?].
The German Dachverband Osteologie e. V. has updated the S3 guideline "prophylaxis, diagnostic and therapy of osteoporosis in adults" ( http://www.dv-osteologie.de ). Osteoporotic fractures are a frequent cause of disability and loss of quality of life in old age. Maintenance of muscle function and balance, a daily calcium intake of 1000 mg, sufficient vitamin D and a prudent use of fall- and osteoporosis-associated drugs are key components of fracture prevention. The German guideline recommends that a specific long-term osteoporosis medication (e. g. bisphosphonates, raloxifene, strontiumranelat, parathyroid hormone) should be initiated in individuals with a 30% 10-year risk for hip fractures and vertebral fractures.
Jehle
P M
PM
Klinik für Innere Medizin und KfH Nierenzentrum, Ev. Krankenhaus Paul Gerhardt Stift, Paul Gerhardt Strasse 42-45, 06886, Lutherstadt Wittenberg, Deutschland. p.jehle@pgdiakonie.de
Pfeilschifter
J
J
D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D002136:Calcium, Dietary; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control*; D005858:Germany; D006801:Humans; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome; D014807:Vitamin D / Q000008:administration & dosage*
D050071:Bone Density Conservation Agents; D002136:Calcium, Dietary; D014807:Vitamin D